Zobrazeno 1 - 10
of 53
pro vyhledávání: '"John M. Kaczmar"'
Autor:
Sarah R. Sutton, April N. Taniguchi, Shaun A. Nguyen, William G. Albergotti, John M. Kaczmar, Alexandra E. Kejner, Jason G. Newman
Publikováno v:
Cancers, Vol 15, Iss 9, p 2475 (2023)
In patients receiving treatment for head and neck cancer (HNC), there is a correlation between quality of life (QoL) scores and treatment outcomes. Higher QoL scores have been associated with improved survival. Despite this, the assessment of QoL in
Externí odkaz:
https://doaj.org/article/11cc0e9dc462492e947d4248d5432b2f
Autor:
Christian M. Shannon, Neil K. Mehta, Hong Li, Shaun A. Nguyen, Sina Koochakzadeh, Dirk M. Elston, John M. Kaczmar, Terry A. Day
Publikováno v:
Cancers, Vol 15, Iss 4, p 1229 (2023)
Purpose: The objective was to determine the effects of the anatomic site of a cutaneous melanoma on the survival outcomes of diagnosed individuals. Methods: We conducted a cross-sectional study using data from the Surveillance, Epidemiology, and End
Externí odkaz:
https://doaj.org/article/9eb59a3ab832496293da1fe67c4b5da4
Autor:
Hannah M. Knochelmann, Joshua D. Horton, Sixue Liu, Kent Armeson, John M. Kaczmar, Megan M. Wyatt, Mary S. Richardson, Shirley H. Lomeli, Ying Xiong, Evan M. Graboyes, Eric J. Lentsch, Joshua D. Hornig, Judith Skoner, Seth Stalcup, Maria V. Spampinato, Elizabeth Garrett-Mayer, Elizabeth C. O’Quinn, Cynthia D. Timmers, Martin J. Romeo, John M. Wrangle, M. Rita I. Young, Mark P. Rubinstein, Terry A. Day, Roger S. Lo, Chrystal M. Paulos, David M. Neskey
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 10, Pp 100426- (2021)
Summary: Oral cavity squamous cell carcinoma (OCSCC) is a prevalent surgically treated subset of head and neck cancer with frequent recurrence and poor survival. Immunotherapy has demonstrated efficacy in recurrent/metastatic head and neck cancer. Ho
Externí odkaz:
https://doaj.org/article/106d0eef51b345229c78936aef78ee40
Autor:
Flora Yan, Hannah M. Knochelmann, Patrick F. Morgan, John M. Kaczmar, David M. Neskey, Evan M. Graboyes, Shaun A. Nguyen, Besim Ogretmen, Anand K. Sharma, Terry A. Day
Publikováno v:
Cancers, Vol 12, Iss 6, p 1543 (2020)
Cancers that arise in the head and neck region are comprised of a heterogeneous group of malignancies that include carcinogen- and human papillomavirus (HPV)-driven mucosal squamous cell carcinoma as well as skin cancers such as cutaneous squamous ce
Externí odkaz:
https://doaj.org/article/0ce04653437343d7af2ba61defda2cc5
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Supplementary Figure from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043fabc7d6ca2a922dd6f9f2c01ebdc8
https://doi.org/10.1158/1078-0432.22486398.v1
https://doi.org/10.1158/1078-0432.22486398.v1
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Supplementary Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e63936c171b8dd8ce4ac3c4e149a45
https://doi.org/10.1158/1078-0432.22486401
https://doi.org/10.1158/1078-0432.22486401
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Purpose:Patients with resected, local–regionally advanced, head and neck squamous cell carcinoma (HNSCC) have a one-year disease-free survival (DFS) rate of 65%–69% despite adjuvant (chemo)radiotherapy. Neoadjuvant PD-1 immune-checkpoint blockade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a1cdf4b8a3cbedd3c442a8c16f210c9
https://doi.org/10.1158/1078-0432.c.6532305
https://doi.org/10.1158/1078-0432.c.6532305
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Supplementary Table from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b6ed52b9af5a2f08064d83b3e3e3f4
https://doi.org/10.1158/1078-0432.22486380
https://doi.org/10.1158/1078-0432.22486380
Autor:
Michael H. Froehlich, Michael C. Shih, Lindsey Shehee, Anvesh R. Kompelli, Alana Aylward, Shaun A. Nguyen, John M. Kaczmar, Cherie Ann Nathan, Terry Day, David M. Neskey
Publikováno v:
Head & Neck. 44:1725-1736
Data describing features and management of oropharyngeal neuroendocrine carcinomas (NEC) remain sparse. A systematic review was performed. Patients were stratified by treatment modality and examined for disease progression and survival outcomes. Nine
Publikováno v:
Targeted Oncology. 16:743-752
Results of early trials led to FDA approval of immune checkpoint inhibitors (ICIs) for advanced and recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (CSCC). Updated data from these trials are pending and extent of survival outcomes is und